Zymeworks Inc. (ZYME) by event type
ZYME moves most on coverage initiations — a median of +0.99% at 30 minutes across 21 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the ZYME overview →
How ZYME reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 311 of 2,717 | 23 | +0.56% | 57% | +0.10% |
| Coverage initiations 158 of 2,283 | 21 | +0.99% | 67% | +1.72% |
| Rating reiterations 523 of 3,522 | 67 | +0.17% | 55% | +0.23% |
| Price-target raises 23 of 1,790 | 20 | +0.71% | 65% | +0.04% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how ZYME usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · ZYME overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Abeona Therapeutics Inc. (ABEO) | 438 | +0.09% | 51% |
| KalVista Pharmaceuticals, Inc. (KALV) | 438 | 0.00% | 50% |
| Exact Sciences Corporation (EXAS) | 437 | +0.08% | 56% |
| IMMUNE PHARMACEUTICALS INC NE (IMNP) | 437 | -0.77% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.